Sara N Edmond
Overview
Explore the profile of Sara N Edmond including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
540
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Edmond S, Kerns R, Geda M, Luther S, Edwards R, Taylor S, et al.
Pain Med
. 2024 Aug;
25(Supplement_1):S14-S16.
PMID: 39163504
No abstract available.
2.
Muller R, Driscoll M, DeRycke E, Edmond S, Becker W, Bastian L
J Behav Med
. 2024 Aug;
47(6):994-1001.
PMID: 39143444
This analysis was part of the Pain and Smoking Study (PASS), a randomized trial of a cognitive behavioral intervention (CBI) for Veterans with chronic pain who smoke. The objective of...
3.
Daniels S, Cave S, Wagner T, Perez T, Edmond S, Becker W, et al.
Health Serv Res
. 2024 Jul;
59 Suppl 2:e14345.
PMID: 38956400
Objective: To determine the budget impact of implementing multidisciplinary complex pain clinics (MCPCs) for Veterans Health Administration (VA) patients living with complex chronic pain and substance use disorder comorbidities who...
4.
Edmond S, Becker W
J Gen Intern Med
. 2024 May;
39(11):2108-2109.
PMID: 38806796
No abstract available.
5.
MacLean R, Ankawi B, Driscoll M, Gordon M, Frankforter T, Nich C, et al.
JMIR Res Protoc
. 2024 Mar;
13:e54342.
PMID: 38506917
Background: Chronic pain is common among individuals with opioid use disorder (OUD) who are maintained on medications for OUD (MOUD; eg, buprenorphine or methadone). Chronic pain is associated with worse...
6.
Black A, Edmond S, Frank J, Abelleira A, Snow J, Wesolowicz D, et al.
Subst Use Addctn J
. 2024 Mar;
46(1):155-159.
PMID: 38469833
Guidelines recommend strategies to optimize opioid medication safety, including frequent reassessment of the benefits and harms of long-term opioid therapy. Prescribers, who are predominantly primary care providers (PCPs), may lack...
7.
Wesolowicz D, Spelman J, Edmond S, Schwartz A, Kravetz J, Edens E, et al.
Pain Med
. 2023 Oct;
25(3):226-230.
PMID: 37847654
Objective: Buprenorphine is effective for chronic pain and safer than full-agonist opioids; however, limited education about and support for buprenorphine can result in under-prescribing in primary care and reduced access...
8.
Becker W, Frank J, Edmond S, Starrels J
Addiction
. 2023 Sep;
119(1):4-5.
PMID: 37766414
No abstract available.
9.
Edmond S, Wesolowicz D, Snow J, Currie S, Jankelovits A, Chhabra M, et al.
J Pain
. 2023 Aug;
25(1):132-141.
PMID: 37549775
Guidelines recommend consideration of modification, tapering, or discontinuation of long-term, full-agonist opioid therapy when harms outweigh benefits; one alternative to tapering or discontinuing full-agonist opioids for the management of chronic...
10.
Rogers D, Frank J, Wesolowicz D, Nolan C, Schroeder A, Falker C, et al.
BMC Prim Care
. 2023 Jun;
24(1):134.
PMID: 37386370
Background: Chronic pain is among the most common conditions presenting to primary care and guideline-based care faces several challenges. A novel pain management program, Video-Telecare Collaborative Pain Management (VCPM), was...